Assignee
FURET PASCAL
FR·15 granted patents·7 pending applications·30 citations·filing 2005–2018
Top patents by PatentIndex Score
22 records- 0190US8969341B2Pyrazolopyrrolidine compoundsFURET PASCAL·Filed 2012·Granted Mar 3, 2015·8 cites·13 claims
- 0285US9340537B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted May 17, 2016·4 cites·3 claims
- 0385US9278981B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Mar 8, 2016·6 cites·18 claims
- 0484US8389526B23-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivativesFURET PASCAL·Filed 2010·Granted Mar 5, 2013·4 cites·9 claims
- 0578US8476294B21H-imidazo[4,5-c]quinolinone derivativesFURET PASCAL·Filed 2010·Granted Jul 2, 2013·5 cites·3 claims
- 0672US8822468B23-Methyl-imidazo[1,2-b]pyridazine derivativesFURET PASCAL·Filed 2009·Granted Sep 2, 2014·2 cites·3 claims
- 0768US9403827B2Substituted purinone compoundsFURET PASCAL·Filed 2014·Granted Aug 2, 2016·1 cites·10 claims
- 0867US8273882B2Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitorsFURET PASCAL·Filed 2009·Granted Sep 25, 2012·0 cites·22 claims
- 0958US8674099B2Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitorsFURET PASCAL·Filed 2012·Granted Mar 18, 2014·0 cites·7 claims
- 1058US2018134695A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1FURET PASCAL·Filed 2018·Application pending·0 cites
- 1157US9896444B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Feb 20, 2018·0 cites·5 claims
- 1257US8536175B2Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitorsFURET PASCAL·Filed 2012·Granted Sep 17, 2013·0 cites·12 claims
- 1352US2006205673A12-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivativesFURET PASCAL·Filed 2006·Application pending·0 cites
- 1451US9458112B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Oct 4, 2016·0 cites·8 claims
- 1550US9315489B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Apr 19, 2016·0 cites·20 claims
- 1650US2005239716A12-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylboronic acid derivativesFURET PASCAL·Filed 2005·Application pending·0 cites
- 1750US2006211747A1Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this methodFURET PASCAL·Filed 2005·Application pending·0 cites
- 1846US2014005163A11h-imidazo[4,5-c]quinolinone derivativesFURET PASCAL·Filed 2013·Application pending·0 cites
- 1943US8859586B2Cyclohexyl isoquinolinone compoundsFURET PASCAL·Filed 2012·Granted Oct 14, 2014·0 cites·15 claims
- 2041US9795596B2Pharmaceutical diagnosticFURET PASCAL·Filed 2013·Granted Oct 24, 2017·0 cites·2 claims
- 2140US2014249139A1Quinazoline DerivativesFURET PASCAL·Filed 2012·Application pending·0 cites
- 2235US2010311714A11H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDSFURET PASCAL·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →